Stina Garvin

1.8k total citations
25 papers, 1.4k citations indexed

About

Stina Garvin is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Stina Garvin has authored 25 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 12 papers in Molecular Biology and 6 papers in Cancer Research. Recurrent topics in Stina Garvin's work include Estrogen and related hormone effects (5 papers), Angiogenesis and VEGF in Cancer (5 papers) and Cancer-related Molecular Pathways (4 papers). Stina Garvin is often cited by papers focused on Estrogen and related hormone effects (5 papers), Angiogenesis and VEGF in Cancer (5 papers) and Cancer-related Molecular Pathways (4 papers). Stina Garvin collaborates with scholars based in Sweden, United Kingdom and Denmark. Stina Garvin's co-authors include Charlotta Dabrosin, Karin Öllinger, Ulrika W. Nilsson, Fumitaka Ikomi, Toshio Ohhashi, Piotr Religa, David G. Jackson, Steen Dissing, Meit A. Björndahl and Katerina Tritsaris and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Cancer Cell and British Journal of Cancer.

In The Last Decade

Stina Garvin

25 papers receiving 1.4k citations

Peers

Stina Garvin
Limei Liu China
Bingyin Shi China
Sabarish Ramachandran United States
Beatrice Faraglia Italy
Liang Cheng China
Shu Okamura Japan
Cheng‐Chi Chang Taiwan
Lyndsay V. Rhodes United States
Valentina Grossi Italy
Limei Liu China
Stina Garvin
Citations per year, relative to Stina Garvin Stina Garvin (= 1×) peers Limei Liu

Countries citing papers authored by Stina Garvin

Since Specialization
Citations

This map shows the geographic impact of Stina Garvin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stina Garvin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stina Garvin more than expected).

Fields of papers citing papers by Stina Garvin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stina Garvin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stina Garvin. The network helps show where Stina Garvin may publish in the future.

Co-authorship network of co-authors of Stina Garvin

This figure shows the co-authorship network connecting the top 25 collaborators of Stina Garvin. A scholar is included among the top collaborators of Stina Garvin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stina Garvin. Stina Garvin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Molin, Jesper, et al.. (2021). The human‐in‐the‐loop: an evaluation of pathologists’ interaction with artificial intelligence in clinical practice. Histopathology. 79(2). 210–218. 20 indexed citations
3.
Gimm, Oliver, et al.. (2021). Increased diagnostic sensitivity of palpation‐guided thyroid nodule fine‐needle aspiration cytology by BRAF V600E‐mutation analysis. The Journal of Pathology Clinical Research. 7(6). 556–564. 3 indexed citations
4.
Garvin, Stina, et al.. (2019). Differences in intra-tumoral macrophage infiltration and radiotherapy response among intrinsic subtypes in pT1-T2 breast cancers treated with breast-conserving surgery. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 475(2). 151–162. 12 indexed citations
5.
Garvin, Stina, et al.. (2018). Tumor cell expression of CD163 is associated to postoperative radiotherapy and poor prognosis in patients with breast cancer treated with breast-conserving surgery. Journal of Cancer Research and Clinical Oncology. 144(7). 1253–1263. 39 indexed citations
6.
Haapaniemi, Aaro, Lovisa Farnebo, Jussi Tarkkanen, et al.. (2017). WRAP53β, survivin and p16INK4a expression as potential predictors of radiotherapy/chemoradiotherapy response in T2N0-T3N0 glottic laryngeal cancer. Oncology Reports. 38(4). 2062–2068. 11 indexed citations
7.
Haglund, Felix, Stina Garvin, Inga‐Lena Nilsson, et al.. (2016). Detailed Lymph Node Sectioning of Papillary Thyroid Carcinoma Specimen Increases the Number of pN1a Patients. Endocrine Pathology. 27(4). 346–351. 6 indexed citations
8.
9.
10.
Welander, Jenny, Stina Garvin, Lars Johannes Isaksson, et al.. (2013). GermlineSDHAMutation Detected by Next-Generation Sequencing in a Young Index Patient With Large Paraganglioma. The Journal of Clinical Endocrinology & Metabolism. 98(8). E1379–E1380. 19 indexed citations
11.
Jerhammar, Fredrik, Rebecca Ceder, Stina Garvin, et al.. (2010). Fibronectin 1 is a potential biomarker for radioresistance in head and neck squamous cell carcinoma. Cancer Biology & Therapy. 10(12). 1244–1251. 61 indexed citations
12.
13.
Garvin, Stina, et al.. (2009). The number of identified lymph node metastases increases continuously with increased total lymph node recovery in pT3 colon cancer. Acta Oncologica. 48(8). 1152–1156. 16 indexed citations
14.
Garvin, Stina & Charlotta Dabrosin. (2008). In vivo measurement of tumor estradiol and Vascular Endothelial Growth Factor in breast cancer patients. BMC Cancer. 8(1). 73–73. 41 indexed citations
15.
Björndahl, Meit A., Piotr Religa, Steven Clasper, et al.. (2006). PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis (vol 6, pg 333, 2004). Cancer Cell. 9. 239–239. 23 indexed citations
16.
Cao, Renhai, Meit A. Björndahl, Piotr Religa, et al.. (2006). PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis. Cancer Cell. 9(3). 239–239. 8 indexed citations
17.
Nilsson, Ulrika W., Stina Garvin, & Charlotta Dabrosin. (2006). MMP-2 and MMP-9 activity is regulated by estradiol and tamoxifen in cultured human breast cancer cells. Breast Cancer Research and Treatment. 102(3). 253–261. 78 indexed citations
18.
Garvin, Stina, Ulrika W. Nilsson, Fredrik Huss, Gunnar Kratz, & Charlotta Dabrosin. (2006). Estradiol increases VEGF in human breast studied by whole-tissue culture. Cell and Tissue Research. 325(2). 245–251. 31 indexed citations
19.
Garvin, Stina, Karin Öllinger, & Charlotta Dabrosin. (2005). Resveratrol induces apoptosis and inhibits angiogenesis in human breast cancer xenografts in vivo. Cancer Letters. 231(1). 113–122. 289 indexed citations
20.
Cao, Renhai, Meit A. Björndahl, Piotr Religa, et al.. (2004). PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis. Cancer Cell. 6(4). 333–345. 420 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Limei Liu Breakdown of academic impact, for papers by Bingyin Shi Breakdown of academic impact, for papers by Sabarish Ramachandran Breakdown of academic impact, for papers by Beatrice Faraglia Breakdown of academic impact, for papers by Liang Cheng Breakdown of academic impact, for papers by Shu Okamura Breakdown of academic impact, for papers by Cheng‐Chi Chang Breakdown of academic impact, for papers by Lyndsay V. Rhodes Breakdown of academic impact, for papers by Valentina Grossi
Rankless by CCL
2026